ProCE Banner Activity

Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era—Audio Recap

Podcast Episodes
In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and even improving care of patients with HCC or liver transplantation despite the challenges posed by the COVID-19 pandemic.

Released: March 23, 2022

Expiration: March 22, 2023

No longer available for credit.

Share

Faculty

Graham R. Foster

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Paul Y. Kwo

Paul Y. Kwo, MD

Professor of Medicine
Medical Director of Transplantation
Division of Medicine/Gastroenterology/Hepatology
Indiana University School of Medicine
Indianapolis, Indiana

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grants provided by:

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Graham R. Foster, FRCP, PhD, has disclosed that he has received consulting fees from Biogen, GlaxoSmithKline, and UniQure and fees for non-CME/CE services from AbbVie, Gilead Sciences, and MSD.

Paul Y. Kwo, MD

Professor of Medicine
Medical Director of Transplantation
Division of Medicine/Gastroenterology/Hepatology
Indiana University School of Medicine
Indianapolis, Indiana

Paul Y. Kwo, MD, has disclosed that he has received consulting fees from AbbVie, Aligos, Antios, Drug Farm, Enanta, Gilead Sciences, and Janssen and funds for research support from Assembly, Bristol-Myers Squibb, Eiger, Gilead Sciences, and Janssen.